$3.65 Bn Fertility Supplement Markets by Ingredient, Product and End User – Global Opportunity Analysis and Industry Forecast, 2020-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Fertility supplement market by Ingredient, Product and End User: Global Opportunity Analysis and Industry Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

The global fertility supplements market generated $1,754.00 million in 2020 and is projected to reach $3,652.50 million by 2030, growing at a CAGR of 7.50% from 2021 to 2030.

Fertility supplements are the chemical supplements or drugs that enhance the fertility levels in males and females. It contain hormones, antioxidants and other ingredients that can boost fertility. Currently, certain fertility supplements contain herbal ingredients and are more in demand in the fertility supplements market.

In males, the fertility supplements help to increase the sperm count, motility and zinc boosts testosterone levels. And, in females, the supplements help to elevate the estrogen levels. Some common fertility supplements are Acetyl L-carnitine, Acetyl L-carnitine, Folic acid, Vitamins, Minerals and others.

These fertility supplements have advantages such as it builds hormones that further supports the reproductive procedure. With the help of these supplements the ovulation cycle is managed, and contains nutrients and minerals which are essential for the development of fetus.

The global fertility supplements market is expected to witness a substantial growth in the future, owing to high incidence of infertility cases and emerging trend of delayed pregnancies among women. In addition, the prevalence of smoking is higher in developed countries than in emerging economies.

Even fertility treatments such as IVF is not helpful in conceiving for smoking women, which has prompted fertility manufacturers to look for ingredients that can eliminate the effects of smoking on fertility. This factor is anticipated to create growth opportunities for fertility supplement manufacturers over the forecast period.

Furthermore, there is growing adoption of herbal medicines (botanicals) owing to the increasing concerns about the harmful impacts associated with the traditional pharmaceutical drugs is poised to generate new opportunities for the fertility supplements manufacturers, leading to the growth of the fertility supplements market.

Various public initiatives to raise awareness regarding advancements in fertility supplements among consumers and its superior technology have helped the industry gain a further boost. However, the lack of awareness among the population of low-income economies is anticipated to restrain the growth of the global fertility supplements market.

According to the American Society for Reproductive Medicine, in the U.S., approximately 35% and 30% of men and women of reproductive age smoke cigarettes. The prevalence of smoking is higher in developed countries than in emerging economies.

Even fertility treatments such as IVF may not be helpful in conceiving for smoking women, which has prompted fertility manufacturers to look for ingredients that can eliminate the effects of smoking on fertility. This factor is anticipated to create growth opportunities for the fertility supplement manufacturers over the forecast period.

Increasing importance of food products such as avocados, olive oil, whole grains, and high fat dairy products used in increasing fertility is expected to amplify the scope of functional food and beverages in the near future resulting in hindering the overall growth.

MARKET DYNAMICS

Drivers

• Continuous decline in fertility rates
• Delayed pregnancies in women

Restraints

• Technological advancements with respect to fertility treatment restrain the market growth

Opportunity

• Rising demand for natural ingredients

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Fairhaven Health
• Coast Science
• Lenus Pharma GesmbH
• Active Bio Life Science GmbH
• Orthomol
• Exeltis USA, Inc.
• PregPrep LLC
• Bionova
• TTK HealthCare Ltd.
• Fertility Nutraceuticals LLC

KEY MARKET SEGMENTS

By Ingredient

• Natural
• Synthetic/Blend of Natural & Synthetic

By Product

• Capsules
• Tablets
• Soft Gels
• Powders
• Liquids

By End User

• Men
• Women

By Region

North America

• U.S.
• Canada
• Mexico

Europe

• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

Asia-Pacific

• Japan
• China
• India
• Australia
• Rest of Asia-Pacific

LAMEA

• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

For more information about this report visit https://www.researchandmarkets.com/r/ow879o

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900